Alar Pharmaceuticals Inc. (TPEX:6785)

Alar Pharmaceuticals Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 25, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	11,490	20,307	9,452	11,942	6,555	2,608
Market Cap Growth	14.67%	114.84%	-20.85%	82.17%	151.37%	-6.63%
Enterprise Value	9,197	17,972	7,028	11,326	6,046	2,053
Last Close Price	172.00	304.00	141.26	208.00	114.18	45.42
PE Ratio	-	-	520.21	31.21	-	-
PS Ratio	4173.48	7376.39	1624.93	25.45	8193.75	-
PB Ratio	4.78	8.45	3.79	13.31	12.74	4.88
P/TBV Ratio	4.78	8.45	3.79	13.31	12.74	4.88
P/FCF Ratio	-	-	-	30.06	-	-
P/OCF Ratio	-	-	-	29.59	-	-
EV/Sales Ratio	-	6528.21	1208.22	24.14	7557.22	-
EV/EBITDA Ratio	-	-	-	29.22	-	-
EV/EBIT Ratio	-	-	-	29.38	-	-
EV/FCF Ratio	-52.89	-	-	28.51	-	-
Debt / Equity Ratio	0.00	0.00	0	0.00	0.01	0.00
Debt / EBITDA Ratio	-	-	-	0.00	-	-
Debt / FCF Ratio	-	-	-	0.00	-	-
Net Debt / Equity Ratio	-0.95	-0.95	-0.97	-1.00	-0.94	-0.97
Net Debt / EBITDA Ratio	14.07	14.07	37.14	-2.31	10.95	5.71
Net Debt / FCF Ratio	13.19	13.19	34.80	-2.25	14.19	7.97
Asset Turnover	0.00	0.00	0.00	0.63	0.00	-
Quick Ratio	30.84	30.84	44.14	11.98	90.70	116.51
Current Ratio	31.59	31.59	44.33	12.08	92.66	118.67
Return on Equity (ROE)	-3.26%	-3.26%	1.07%	54.21%	-3.79%	-11.34%
Return on Assets (ROA)	-4.16%	-4.16%	-2.41%	32.22%	-5.47%	-10.20%
Return on Invested Capital (ROIC)	-170.98%	-195.31%	-104.19%	2250.88%	-197.02%	-336.68%
Return on Capital Employed (ROCE)	-7.00%	-7.00%	-2.70%	42.90%	-9.00%	-17.40%
Earnings Yield	-0.69%	-0.39%	0.19%	3.20%	-0.30%	-2.46%
FCF Yield	-1.51%	-0.86%	-0.74%	3.33%	-0.52%	-2.49%
Dividend Yield	0.14%	-	0.18%	0.72%	-	-
Payout Ratio	-	-	551.46%	-	-	-
Buyback Yield / Dilution	-1.11%	-1.11%	-16.08%	-0.09%	-	-14.21%
Total Shareholder Return	-0.97%	-1.11%	-15.90%	0.63%	-	-14.21%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.